𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Shame and Guilt in First-Episode Schizophrenia and Schizoaffective Disorders

✍ Scribed by Rachel Miller; Susan E. Mason

Publisher
Springer US
Year
2005
Tongue
English
Weight
72 KB
Volume
35
Category
Article
ISSN
0022-0116

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Shame and guilt in women with eating-dis
Shame and guilt in women with eating-disorder symptomatology
✍ John Burney; Harvey J. Irwin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views

The relationship of shame and guilt to eating-disorder symptomatology was investigated in a sample of 97 Australian women. In terms of the objective of predicting the severity of eating disturbance, the study explored the predictive utility of proneness to shame and guilt in a global sense, shame an

Familial syndrome patterns in schizophre
Familial syndrome patterns in schizophrenia, schizoaffective disorder, mania, and depression
✍ Hans H. Stassen; Christian Scharfetter; George Winokur; Jules Angst πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 804 KB

A major problem with studies in the field of quantitative genetics is that of phenotypical heterogeneity. In particular, such heterogeneities show up in psychiatric investigations: index cases often tend to display more severe forms of disorders than the respective affected relatives. The principal

Efficacy and safety of long-acting rispe
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; MariΓ«lle Eerd πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi